Article
A Lactylation-Related Radiosensitivity Index Predicts Differential Radiotherapy Benefit in Head and Neck Squamous Cell Carcinoma
2026-04-21
Abstract excerpt
<title>Abstract</title> <p>Radiotherapy (RT) is integral to the management of head and neck squamous cell carcinoma (HNSCC), yet no validated biomarker exists to predict which patients benefit most. Lactylation, a metabolic post-translational modification, has been linked to DNA damage repair (DDR) and therapeutic resistance, but no lactylation-based radiosensitivity biomarker has been established in HNSCC. Here,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 80882dbe-86a4-52c8-af51-3598bbb2d43e
- DOI
- 10.21203/rs.3.rs-9250884/v1
